| Filed On | Filing |
|---|---|
| 06 Nov 2026 |
Form 4: Jordan Rhonda L, Director
Received 3,733 shares by exercise or conversion ($124K) · Sold 3,733 shares ($294K) |
| 05 Nov 2026 | 144 |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
North Bethesda, MD, November 4, 2026 -- ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a focused premier industrial compounder, today announced financial results for the third quarter of 2026. |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 07 Oct 2026 | SCHEDULE 13G/A |
| 02 Oct 2026 |
Form 4: Martin Sebastien, Director
Received 198 shares by exercise or conversion |
| 02 Oct 2026 |
Form 4: Rales Mitchell P, Director
Received 892 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Lutz Robert S, Director
Granted 494 Deferred Stock Units |
| 01 Oct 2026 |
Form 4: Teirlinck Didier P, Director
Granted 200 Deferred Stock Units |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 10 Aug 2026 |
Form 4: Jordan Rhonda L, Director
Received 1,000 shares by exercise or conversion ($33.3K) · Sold 1,000 shares ($95K) |
| 07 Aug 2026 | 144 |
| 06 Aug 2026 |
8-K/A: Financial Statements and Exhibits
The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements. |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
North Bethesda, MD, August 6, 2026 -- ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a focused premier industrial compounder, today announced financial results for the second quarter of 2026. |
| 31 Jul 2026 | SCHEDULE 13G |
| 17 Jul 2026 |
Form 4: Bhagwakar Ranjana N, EVP, Business Operations
Granted 15,777 Restricted Stock Units |
| 06 Jul 2026 |
Form 4: Bhagwakar Ranjana N, EVP, Business Operations
Granted 9,048 Restricted Stock Units · Granted 7,056 Employee Stock Options (right to buy) · Granted 58,056 Performance Stock Option (right to buy) |
| 06 Jul 2026 |
Form 3: Bhagwakar Ranjana N, EVP, Business Operations
No securities owned |
Loading...